Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia [1]

European Journal of Haematology

Volumn 78, Issue 6, 2007, Pages 545-

  Sasaki, Makoto ^a   Sugimoto, Koichi ^a   Kawahara, Shimpei ^a   Yasuda, Hajime ^a   Suto, Hiroko ^a   Oshimi, Kazuo ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ASPARAGINASE; DEXAMETHASONE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE;

ADULT; CANCER CHEMOTHERAPY; CANCER CONTROL; CASE REPORT; CHILL; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DRUG FEVER; DYSPNEA; EDEMA; FLOW CYTOMETRY; HUMAN; HYPERTENSION; LABORATORY TEST; LETTER; LEUKEMIA; LEUKEMIA CELL; MALE; NATURAL KILLER CELL; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOCYTIC; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS;

EID: 34248589685     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00855.x     Document Type: Letter

References (3)

1. Golay J, Manganini M, Rambaldi A, Introna M. Effect of alemtuzumab on neoplastic B cells. Haematologica 2004 89 : 1476 83.
2. Stanglmaier M, Reis S, Hallek M. Rituximab and alemtuzumab induce a nonclassic, caspase-independent apoptotic pathway in B-lymphoid cell lines and in chronic lymphocytic leukemia cells. Ann Hematol 2004 83 : 634 45.
3. Murdock J, Jaffe ES, Wilson WH, McManus DT, Alexander HD, Morris TC. Aggressive natural killer cell leukemia/lymphoma: case report, use of Telesynergy and review of the literature. Leuk Lymphoma 2004 45 : 1269 73.